A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Personalis, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 92,841 shares of PSNL stock, worth $791,933. This represents 0.06% of its overall portfolio holdings.

Number of Shares
92,841
Previous 55,583 67.03%
Holding current value
$791,933
Previous $195,000 212.31%
% of portfolio
0.06%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025

BUY
$3.0 - $6.57 $111,774 - $244,785
37,258 Added 67.03%
92,841 $609,000
Q1 2025

May 09, 2025

BUY
$3.51 - $6.64 $106,756 - $201,955
30,415 Added 120.85%
55,583 $195,000
Q4 2024

Feb 12, 2025

BUY
$3.38 - $6.26 $34,019 - $63,006
10,065 Added 66.64%
25,168 $145,000
Q3 2024

Oct 16, 2024

BUY
$1.19 - $6.34 $5,359 - $28,555
4,504 Added 42.49%
15,103 $81,000
Q2 2024

Jul 29, 2024

BUY
$1.17 - $1.65 $12,400 - $17,488
10,599 New
10,599 $12,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $392M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.